BUZZ-Avantor falls after Q4 sales miss

Life sciences firm Avantor's shares AVTR.K fall 4.37% to $20.75 premarket

Co posts Q4 sales of $1.69 billion, which missed analysts' estimates of $1.71 billion, as per data compiled by LSEG

Sales hurt by foreign currency and the divestiture of its clinical service business

Co divested its clinical service business to Audax private equity firm in a deal valued at ~$650 million last year

Sees 2025 adj profit in the range of $1.02 to $1.10 per share

Analysts estimate annual profit of $1.10 per share

Up to last close, stock had fallen 11.93% in the last 12 months